Category: New products
-
Inexpensive Pumps Devised for Portable Labs-on-Chips
An engineering lab developed an inexpensive pump without electric power for lab-on-a-chip devices, making these systems more portable for diagnostics.
-
Trial Shows Bioactive Glass Stops Bone Infections
Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics.
-
Nanotech Gel Designed to Treat Snake Bites
A team from University of California in Irvine developed a snake bite treatment that in lab tests stops venom more effectively and at lower cost than current antidotes.
-
Process Converts Food Waste to Auto Tire Materials
Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques.
-
Air Sampling Device Finds Unreported Allergens
A system designed to sample the air in homes of people with allergies found a number of airborne allergens in residences that previously went undetected by other devices.
-
Trial Underway to Test Cancer Immunotherapy Aid
A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system.
-
Messenger RNA Engineered to Produce Antibodies
Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies.
-
Mobile App-Controlled Patch Reduces Migraine Pain
A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines.
-
Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma
A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma.
-
Trial Begins Testing Enhanced Cord Blood Stem Cells
A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient.